Mar 11, 2022 8:00am EST Achieve Life Sciences Announces Expansion of Manufacturing & Quality Operations Team and Granting of Inducement Award
Mar 10, 2022 8:00am EST Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update
Feb 24, 2022 8:00am EST Achieve Life Sciences to Announce Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call and Webcast on March 10, 2022
Feb 03, 2022 8:00am EST Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Award
Feb 02, 2022 8:00am EST Achieve Life Sciences Announces Participation in February Investor Conferences
Jan 25, 2022 8:00am EST Achieve Life Sciences Announces Initiation of the Phase 3 ORCA-3 Clinical Trial Evaluating Cytisinicline for Smoking Cessation
Jan 06, 2022 8:30am EST Achieve Life Sciences to Present at H.C. Wainwright BIOCONNECT Virtual Conference
Jan 04, 2022 8:30am EST Achieve Life Sciences Announces Completion of Last Subject, Last Follow-Up Visit in Phase 3 ORCA-2 Trial of Cytisinicline for Smoking Cessation
Dec 22, 2021 8:30am EST Achieve Life Sciences Announces $25 Million Loan Facility from Silicon Valley Bank to Fund Cytisinicline Smoking Cessation Clinical Development